Laserfiche WebLink
c. When autoclaving mixed waste, precautions must be taken to avoid the release <br />of volatile radionuclides and toxic chemicals. The potential volatility of the <br />mixture when subjected to the elevated temperatures necessary to achieve <br />thermal biological inactivation therefore an important factor in the assessment of <br />these types of mixed wastes. <br />d. Trace chemotherapy and other hazardous drugs should be disposed of by a <br />regulated medical waste company through incineration [ASHP 1995; OSHA <br />1999; Smith 20021. These recommendations are consistent with current <br />knowledge of the toxicity of antineoplastic (cytotoxic, chemotherapeutics, anti- <br />cancer agents, etc.) and other hazardous drugs, that suggest bulk hazardous <br />drugs (i.e. greater than 3% of the initial volume) not listed under RCRA be <br />handled similarly to hazardous waste and disposed of in a RCRA-permitted <br />hazardous waste incinerator. <br />Hawaii Medical Vitification suggest that no greater than 10% of the waste can be <br />disposed of via plasma arc vitirfication. <br />1. No biohazardous waste or potentially infectious materials must be allowed to enter a <br />building's drainage, vacuum, or refuse disposal system without proper sterilization. <br />2. Terminal disposition of biological agents and all materials contaminated or suspected of <br />being contaminated, including dead animals, tissues, plants, plant parts, equipment, <br />etc. must be preceded by inactivation by an approved method for the agents involved <br />prior to disposing or cleaning. <br />C. •Labels, <br />1. A universal biological hazard symbol (UBHS) is used to indicate the actual or <br />potential presence of a biohazard and to identify equipment, containers, rooms, <br />materials, experimental animals, or combination that contain, or are -contaminated with, <br />viable biological commodities. <br />2. Proper identification of biohazardous agents is necessary to alert support personnel <br />who may enter the area, to take precaution and to restrict traffic to hazardous areas. It <br />is the primary responsibility of the principal investigator to identify properly all <br />biohazards. <br />3. The UBHS must be placed so that it can be easily seen and displayed only for the <br />purposes of signifying the presence of actual or potential biological hazards. <br />4. The UBHS is a fluorescent orange or an orange -red color. <br />There is no requirement for the background color as long as there <br />is sufficient contrast to permit the symbol to be clearly defined. The <br />symbol must be as prominent as practical, of a size consistent with <br />the size of the equipment or material to which it is affixed, and <br />easily seen from as many directions as possible. <br />5. Appropriate wording may be used in association with the symbol to indicate the nature <br />or identity of the hazard, name of the individual responsible for its control, precautionary <br />information, etc., but never should this information be superimposed on the symbol. <br />fileWCADocuments and Settings\OwnerWy Documents\P&PUnfection Control 2005\Bioha... 5/5/2005 <br />